A unique model
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
Recent tweets
Retweeted
:
@unain
juillet 26, 2021
RT @unain: I would like to thank @MitacsCanada for funding my research project in collaboration with @Excellthera on deciphering the curati…
Retweeted
:
@DOMAINtx
juillet 26, 2021
RT @DOMAINtx: One more great example of a fruitful collaboration between @DOMAINtx & @IRIC_umontreal ! An nice way to understand the functi…
@IRIC_umontreal
juillet 19, 2021
📣 En ce début de semaine, l’IRIC désire prendre un moment pour remercier chaleureusement la Fondation Richard et Ed… https://t.co/vCim8xzIM9
-
![]()
News Brian Wilhelm awarded with major funding through the new Genomics Integration Program – Human Health initiated by Génome Québec
Brian Wilhelm, Principal Investigator at IRIC and Associate Professor in the Department of Medicine at the Faculty of Medicine of the Université de Montréal, is the recipient of major funding through the new Genomics Integration Program – Human Health, initiated by Génome Québec in collaboration with the Oncopole.
-
![]()
News IRIC salutes the Quebec government for its commitment: $13M invested to bring together the players in the drug discovery and production field
IRIC is delighted by the creation of “Médicament Québec”, a major strategic hub whose mission is to promote greater autonomy and increase Quebec’s drive with respect to drug discovery, development and production.
-
![]()
News Appointment of Clarissa Desjardins and renewal of Robert Paré and Jacques Bernier’s mandate on the IRIC’s Board of Directors
IRIC is pleased to announce the appointment of Dr. Clarissa Desjardins as a new member of the Board of Directors as well as the renewal of Mtre Robert Paré and Mr. Jacques Bernier’s mandate as a member of the Board by the Executive Committee of the Université de Montréal.
-
![]()
News Fonds vaccin thérapeutique contre le cancer: Donations that make a real difference
In early 2020, IRIC created its brand new “Fonds vaccin thérapeutique contre le cancer”, a fund initiated by Dr. Robert Patenaude with a personal contribution of $25,000. The objective was to support the scientists involved in the project, namely the team led by Dr. Claude Perreault, in collaboration with the teams led by Sébastien Lemieux and Pierre Thibault, who work tirelessly to change the life of people affected by cancer.
-
![]()
News Fondation Marcel et Rolande Gosselin: A major donation renewal for IRIC’s chemolibrary
Convinced that IRIC’s model contributes to achieving the mission of the Fondation Marcel et Rolande Gosselin, and excited about the recent advances generated by the Institute’s research teams, the Trustees of the Fondation Marcel et Rolande Gosselin announce a $500,000 donation renewal for IRIC’s chemolibrary.
-
![]()
News Aubry-Bouvier donations: An exceptional legacy to support the next generation of scientists
Because the next generation of scientists means so much to them, IRIC’s Chief Executive Officer, Mr. Michel Bouvier, and his partner, Ms. Muriel Aubry, retired Professor and Director of the Department of Biochemistry and Molecular Medicine at the Université de Montréal, are pleased to announce the creation of two endowed funds to support students.
-
![]()
News IRIC participates in the next Forum of the Chamber of Commerce of Metropolitan Montreal
On Monday, May 31, IRIC will take part in the Strategic Forum Universities, CEGEPs, businesses: Working together for a strong, innovative and socially responsible economy, an initiative co-developed by the Chamber of Commerce of Metropolitan Montreal and the FRQs.
-
![]()
News Trang Hoang is the recipient of the 2021 CSMB Jeanne Manery Fisher Award
Trang Hoang, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) and Full Professor in the Department of Pharmacology at the Faculty of Medicine of the Université de Montréal is the recipient of the 2021 Canadian Society for Molecular Biosciences (CSMB) Jeanne Manery Fisher Award.
-
![]()
News Les Rendez-vous Audace 2021: $320,000 raised to support IRIC’s cancer research efforts
Exceptionally this year, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal presented a virtual formula of its traditional Audacious fundraising event: Les Rendez-vous Audace. For the occasion, approximately 615 people from 8 countries attended the three free conferences and close to 20 sponsors supported the event. Thanks to the generosity of our partners and donors, a total of $320,000 was raised to accelerate the discovery of better therapies for the benefit of patients.
-
![]()
News Genome-wide screens identify a novel gene that tapers the DNA damage response in human cells with eroded telomeres
Telomeres are DNA sequences that serve as critical caps to protect the ends of chromosomes against degradation, fraying, and fusion with other chromosomes. They play an important role in maintaining genome integrity but in most cells in our body, telomeres become shorter with each cell division as the activity of the telomere maintenance enzyme (TERT) is repressed. After sufficient telomere shortening, the protective telomere structure is lost, activating the tumor-suppressor gene p53 and the DNA damage response. This leads to a non-proliferative state in normal cells called senescence, or to cell death in cancer cells. These inhibitory effects upon cell proliferation are thought to be an important mechanism to prevent the proliferation of damaged cells and the formation of tumors.
Upcoming events
Latest publications
See all publications-
juin 22, 2021 - See all publications